Header Logo

Connection

RAINER LANZ to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications RAINER LANZ has written about Drug Resistance, Neoplasm.
RAINER LANZ
Connection Strength
0.133
Drug Resistance, Neoplasm
  1. An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 2014 Jul; 24(7):809-19.
    View in: PubMed
    Score: 0.074
  2. SRA coactivation of estrogen receptor-alpha is phosphorylation-independent, and enhances 4-hydroxytamoxifen agonist activity. Biochem Biophys Res Commun. 2004 Oct 08; 323(1):332-8.
    View in: PubMed
    Score: 0.038
  3. HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes. Cancer Res. 2016 Mar 15; 76(6):1463-75.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.